Maraviroc

Details

Files

Generic Name:

Maraviroc

Project Status:

Complete

Therapeutic Area:

HIV infection

Manufacturer:

GlaxoSmithKline

Call for patient/clinician input open:

December 9, 2010

Brand Name:

Celsentri

Project Line:

Reimbursement Review

Project Number:

SR0221-000

Call for patient/clinician input closed:

January 31, 2011

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

HIV-1, treatment naïve (adult)

Recommendation Type:

Do not list

Final Recommendation:

July 18, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : December 8, 2010